(Q38269727)

1 September 2017

1 reference

title

Modifiable environmental factors in multiple sclerosis (English)

1 reference

1 September 2017

0 references

1

1 reference

1 September 2017

publication date

1 November 2014

1 reference

Arquivos de Neuro-Psiquiatria

1 September 2017

published in

1 reference

1 September 2017

volume

72

1 reference

1 September 2017

issue

11

1 reference

1 September 2017

page(s)

889-894

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

1 September 2017

1 reference

We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Interferon beta and glatiramer acetate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Concepts of induction and escalation therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Cigarette smoking and autoimmune disease: what can we learn from epidemiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Effects of cigarette smoke exposure and cessation on inflammatory cells and matrix metalloproteinase activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Smokers run increased risk of developing anti-natalizumab antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Smoking and multiple sclerosis: evidence for latitudinal and temporal variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Body size and risk of MS in two cohorts of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Childhood body mass index and multiple sclerosis risk: a long-term cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Role of "Western diet" in inflammatory autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

The interplay between regulatory T cells and metabolism in immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Regulatory T cells, leptin and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

The evidence for a beneficial role of vitamin A in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

The role of retinoic acid in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Retinoid X receptor gamma signaling accelerates CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Vitamin D as an immune modulator in multiple sclerosis, a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Vitamin D as an early predictor of multiple sclerosis activity and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Effects of exercise and physical activity on depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Influence of dietary components on regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Advances in nutritional research on regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Alcohol and substance use in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

What went wrong? The flawed concept of cerebrospinal venous insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Vitamin D and multiple sclerosis: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Biomarkers of disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

Ethanol extract from birch bark (Betula pubescens) suppresses human dendritic cell mediated Th1 responses and directs it towards a Th17 regulatory response in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20140159

10.1590/0004-282X20140159

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference